Articles | EuroIntervention

May 20, 2005

The history of EuroPCR... and why a new journal?

Serruys PW, Marco J

free

• May 20, 2005

Next generation of drug eluting stents 'Sirolimus-analogues'

Buellesfeld L, Grube E

free

• May 20, 2005

The future of cardiac surgery

Trummer G, Beyersdorf F

free

• May 20, 2005

Drug-eluting stents: the equalizers in treatment of bifurcational lesions

Colombo A

free

• May 20, 2005

Treatment of de novo bifurcation lesions: comparison of Sirolimus- and Paclitaxel-eluting stents

Hoye A, van Mieghem C, Ong ATL, Aoki J, Rodríguez-Granillo G, Valgimigli M, Tsuchida K, Sianos G, McFadden E, van der Giessen WJ

free

• May 20, 2005

Influence of technical strategies on the outcome of coronary bifurcation stenting

Lefèvre T, Morice M, Sengottovelu G, Kokis A, Dumas P, Garot P, Louvard Y

free

• May 20, 2005

Relation between the A1166C angiotensin II type 1 receptor gene polymorphism and cardiovascular outcomes after myocardial infarction

Filippi-Codaccioni E, Morello R, Fradin S, Grollier G, Hamon M

free

• May 20, 2005

Primary transcatheter closure of postinfarction ventricular septal defects with the Amplatzer septal occluder - immediate results and up-to 5 years follow-up

Demkow M, Ruzyllo W, Kepka C, Chmielak Z, Konka M, Dzielinska Z, Wilczynski J, Juraszynski Z

free

• May 20, 2005

Percutaneous closure of patent foramen ovale: head-to-head comparison of two different devices

Meier J-M, Berger A, Delabays A, Girod G, Graf D, Lyon X, Roguelov C, Vogt P, Stauffer J-C, Eeckhout E

free

• May 20, 2005

Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9™ eluting stent with a biodegradable polymer coating

Grube E, Hauptmann K-E, Buellesfeld L, Lim V, Abizaid A

free

• May 20, 2005

A randomized comparison of a durable polymer

Serruys PW, Ong ATL, Piek J, Neumann F, van der Giessen WJ, Wiemer M, Zeiher A, Grube E, Haase J, Thuesen L, Hamm C, Otto-Terlouw PC

free

• May 20, 2005

In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention

Thuesen L, Rud Andersen H, Bøtker H, Kristensen SD, Romer Krusell L, Lassen JF

free

• May 20, 2005

Safety and feasibility of Bivalirudin with either Cypher and Taxus drug-eluting stent during percutaneous coronary intervention

Chieffo A, Melzi G, Rogacka R, Ferrari A, Airoldi F, Cosgrave J, Michev L, Montorfano M, Carlino M, Vitrella G, Biondi-Zoccai G, Colombo A

free

• May 20, 2005

Critical limb ischemia: a global epidemic.

Allie D, Hebert CJ, Lirtzman M, Wyatt C, Keller V, Khan MH, Khan MA, Fail P, Vivekananthan K, Mitran E, Allie S

free

• May 20, 2005

Usefulness and clinical impact of a fractional flow reserve-targeted strategy for coronary artery stenting: FROST III, a multicenter prospective registry

Dupouy P, Gilard M, Morelle J-F, Furber A, Aptecar E, Cazaux P, Slama M, Feldman L-J, Wittenberg O, Pernès J-M, Huret B, Commeau P, Boschat J, Teiger E, Lafont A, Steg G, Dubois-Randé J-L

free